Cytogenetic risk score maintains its prognostic significance in
AML
patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation
2019 ◽
Vol 25
(3)
◽
pp. S48-S49
◽
2021 ◽
Vol 27
(3)
◽
pp. S136-S137
2018 ◽
Vol 53
(6)
◽
pp. 683-691
◽
2018 ◽
Vol 24
(11)
◽
pp. 2224-2232
◽
2019 ◽
Vol 25
(3)
◽
pp. S7
◽